BET inhibitors as novel therapeutic agents in breast cancer.

about

The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge

P2860

Q57107038-54D5FBAE-AF19-4C8F-93D9-85E06E5A086B

P2860

BET inhibitors as novel therapeutic agents in breast cancer.

Item

http://www.wikidata.org/entity/Q42378528

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

BET inhibitors as novel therapeutic agents in breast cancer.

@en

BET inhibitors as novel therapeutic agents in breast cancer.

@nl

type

Item

label

BET inhibitors as novel therapeutic agents in breast cancer.

@en

BET inhibitors as novel therapeutic agents in breast cancer.

@nl

prefLabel

BET inhibitors as novel therapeutic agents in breast cancer.

@en

BET inhibitors as novel therapeutic agents in breast cancer.

@nl

P1476

BET inhibitors as novel therapeutic agents in breast cancer

@en

P2093

Atanasio Pandiella

http://www.w3.org/2001/XMLSchema#string

P2860

Structure and ligand of a histone acetyltransferase bromodomain

Selective inhibition of BET bromodomains

A Mammalian bromodomain protein, brd4, interacts with replication factor C and inhibits progression to S phase

Trastuzumab emtansine for HER2-positive advanced breast cancer.

Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Repeated observation of breast tumor subtypes in independent gene expression data sets

Targeting bromodomains: epigenetic readers of lysine acetylation

Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4

The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation

P304

71285-71291

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.19744

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alberto Ocana

Cristina Nieto-Jiménez

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29050361

http://www.w3.org/2001/XMLSchema#string

P932

5642636

http://www.w3.org/2001/XMLSchema#string

BET inhibitors as novel therapeutic agents in breast cancer.

about

P2860

P2860

BET inhibitors as novel therapeutic agents in breast cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932